The cellular neurobiology of depression
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Major depressive disorders, long considered to be of neurochemical origin, have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways may hold promise as new therapeutics for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity that putatively mediates depressive symptoms (Drevets et al, 2002a), or by enhancing the expression of neurotrophic factors that protect medial network function from the effects of repeated stress (Manji et al, 2001).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Manji et al, 2001
In the citing paper
“Somatic antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Manji et al. 2001
In the citing paper
“Depression is often associated with elevated HPA axis activity and increased levels of glucocorticoids, as well as disruption of negative feedback mechanisms21–23.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [22]
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“However, the demonstration that neurogenesis occurs in the adult human brain into senescenc”
BackgroundThe Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332 · cited 1×
“Modest changes in this signaling cascade or in the levels of the Bcl-2 family of proteins (potentially due to genetic, illness or insult-related factors) could therefore profoundly affect cellular viabilit”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“It is thus not altogether surprising that the Global Burden of Disease Study has identified MDDs among the leading causes of disability worldwide, and as illnesses likely to represent an increasingly greater health, societal and economic problem in the coming year”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Current research is examining the potential efficacy of antagonists of corticotropin-releasing factor (CRF), antiglucocorticoids and direct and indirect glutamate antagonist”
BackgroundSelf-citationChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“These studies demonstrate that chronic administration of different classes of antidepressants increases the proliferation and survival of new neuron”
BackgroundPsychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Moreover, lithium also inhibits the activity of glycogen synthase kinase 3β (GSK-3β”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“have demonstrated that an important pathway involved in cell survival and plasticity, the cAMP–CREB cascade, is up-regulated by antidepressant treatmen”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Thus, although MDDs undoubtedly have a strong genetic basis, severe stressors have been associated with a substantial increase in risk for the onset of MDDs in susceptible individuals ( Table 3”
Background
Research works printed but not linked: 4
- Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).
- Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).
- LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).
- Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).
Cited by
Items 901–1,000 of 1,000
Sharma, A., Dhingra, D., & Dutt, R. (2021) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2021.130608 · Cited by 3
Kosuge, A., Kunisawa, K., Iida, T., Wulaer, B., Kawai, T., Tanabe, M., Saito, K., Nabeshima, T., & Mouri, A. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16100 · Cited by 3
“This hypothesis proposes that the levels of monoamine neurotransmit - ters (i.e., serotonin, noradrenaline, and dopamine) in the brains of pa - tients with MDD are insufficient (Dunlop & Nemeroff, 2007; Manji et al., 2001 ).”
Anatomy and connectivity of the Göttingen minipig subgenual cortex (Brodmann area 25 homologue)
Glud, A. N., Zaer, H., Orłowski, D., Nielsen, M. S., Sørensen, J. C. H., & Bjarkam, C. R. (2024) · Brain Structure and Function · doi:10.1007/s00429-024-02855-8 · Cited by 5
“…suffering of treatment resistant depression may display morphological and functional changes in prefrontal areas and circuitry (Drevets et al. 1997; Manji et al. 2001; Botteron et al.2002) Accordingly, deep brain stimulation of the prefrontal BA25 area (BA25-DBS) has been introduced to treat…”
BackgroundOh, D.-R., Kim, Y. K. S. Y., Mun, B. Y., Ko, H., Kim, Y., Kim, M., Oh, K., Hong, J., & Bae, D. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01608-8 · Cited by 3
Hiraki, Y., Araki, R., Fujiwara, H., Ago, Y., Tanaka, T., Toume, K., Matsumoto, K., & Yabe, T. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.11.008 · Cited by 4
Kaur, R., Singh, R., Lalit, Kaur, J., & Rajat (2020) · Current Psychopharmacologye · doi:10.2174/2211556009666200217122202 · Cited by 3
Chen, Y., Nyam, T.-T. E., Tsai, L.-C., Chang, C.-H., Su, C.-L., Ho, C., Chio, C., Gean, P., & Kuo, J. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.09.071 · Cited by 3
Biological Alterations in Depression
Benton, C. S., & Wiltshire, T. (2011) · InTech eBooks · doi:10.5772/27658 · Cited by 5
Quiroz, J. A., Chen, G., Drevets, W. C., Henter, I. D., & Manji, H. K. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.004 · Cited by 4
Self-citationBallesteros, J., Maeztu, A. I., Callado, L. F., Meana, J. J., & Gutiérrez, M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.001 · Cited by 3
“More recently, neuronal and glial cell atrophy and loss have been observed in postmortem cortical brain areas of subjects with mood disorder (Manji et al., 2001; Miguel-Hidalgo and Rajkowska, 2003).”
BackgroundBieling, P., & Grant, D. A. (2007) · Canadian Psychology/Psychologie canadienne · doi:10.1037/cp2007021 · Cited by 7
Crespi, F. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3443-2 · Cited by 3
“Furthermore, depressed patients were found to have subnormal cerebrospinal fluid levels of monoamines and their metabolites (Rush et al. 1996; Bonhomme and Esposito 1998; Manji et al. 2001).”
BackgroundEnjeu neuro-cognitif de la dépression
Jouvent, R. (2007) · L Encéphale · doi:10.1016/s0013-7006(07)79743-9 · Cited by 4
Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience
Hassanzadeh, P. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.15030 · Cited by 3
Affektive Störungen — Neuropsychologie
Hautzinger, M. (2006) · Springer eBooks · doi:10.1007/3-540-30887-3_10 · Cited by 6
Cimarosti, Z., Rossi, S., Tramarin, D., Laval, G., Stabile, P., Giubellina, N., Maton, W. M., Allieri, B., Campi, F., Cooke, J. W. B., et al. (2012) · Organic Process Research & Development · doi:10.1021/op300126e · Cited by 3
Brainstem Circuitry and Emotions
Theofilas, P., Heinsen, H., & Grinberg, L. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00020-2 · Cited by 3
Eckhardt, K., Roth, P. A., Günter, T., Schmidt, S. L., & Feuerstein, T. J. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0664-5 · Cited by 3
Post‐Traumatic Stress Disorder in Animal Models
Cohen, H., Kozlovsky, N., Richter‐Levin, G., & Zohar, J. (2009) · Wiley eBooks · doi:10.1002/9783527628346.ch14 · Cited by 3
Comorbidity, outcome and treatment of dsm-IV major depressive disorder in psychiatric care
Melartin, T. K. (2005) · Helda - University of Helsinki Institutional Repository · Cited by 6
Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
Kamath, J., DeMartinis, N. A., & Handratta, V. D. (2007) · Future Neurology · doi:10.2217/14796708.2.4.361 · Cited by 3
“These acute effects of the antidepressants induce secondary effects on receptor modulation, gene transcription and even neurogenesis that result in clinical improvement through a process that is incompletely understood [22].”
BackgroundPhotobiomodulation for depression in animal models
Salehpour, F., Mahmoudi, J., Sadigh‐Eteghad, S., & Cassano, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815305-5.00014-2 · Cited by 4
Neuroimaging Studies of Effects of Psychotherapy in Depression
Bauer, I. E., & Meyer, T. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.021 · Cited by 2
Tsiouris, J. A., & Flory, M. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1123279 · Cited by 3
“A theory explaining the origin of the hypometabolism observed during MDD was proposed by the first author in 2005 (21), arguing that a form of metabolic depression, a primitive adaptive process for energy preservation that is homologous to the one responsible for mammalian hibernation—and not mitochondrial dysfunction…”
BackgroundHosseini, S. H., Zarghami, M., Haghighian, H. K., Roochi, A. B., Abediankenari, S., Kargar-Soleimanabad, S., & Houshmand, G. (2024) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-144775 · Cited by 4
Messina, G., Rizzi, M., Cordella, R., Castiglione, M., Gambini, O., & Franzini, A. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · Cited by 2
Monnet, F. P. (2004) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2003.07.002 · Cited by 4
Liens entre la pathologie névrotico-anxieuse et la survenue d’une démence ultérieure
Agüera-Ortíz, L., & Osorio, R. (2011) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2011.04.005 · Cited by 3
Serres, F., Sartori, S. B., Halton, A., Pei, Q., Rochat, C., Singewald, N., Sharp, T., & Millan, M. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105059327 · Cited by 2
Fang-lu, L., Xiang, L., Li, J., Shi-quan, C., Liu, H., & Bao, J. (2016) · Journal of Northeast Agricultural University (English edition) · doi:10.1016/s1006-8104(16)30057-5 · Cited by 2
Yin, B., Thönes, S., Cheng, R., Wang, N., Covington, H. E., & Meck, W. H. (2016) · Timing & Time Perception · doi:10.1163/22134468-00002077 · Cited by 2
Nonka, T. G., Repin, A. N., & Сергиенко, Т. Н. (2014) · Cardiosomatics · doi:10.26442/cs45098 · Cited by 2
Holsboer‐Trachsler, E., & Holsboer, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_53 · Cited by 2
Neuroimaging studies of bipolar depression: therapeutic implications
Savitz, J. B., & Drevets, W. C. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_8 · Cited by 2
Self-citationManaging Bipolar Disorder From Urgent Situations to Maintenance Therapy
Jain, R. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0308e07 · Cited by 3
Ko, H., Lee, S. J., Son, H., & Kaang, B. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-16 · Cited by 2
“Of all the brain regions related to depressive disorders, the hippocampus has received the most attention because many patients suffering from depressive disorders exhibit atrophy in the hippocampus, which regulates the stress response by participating in the hypothalamic-pituitary-adrenal (HPA) axis [2,3].”
BackgroundElectrophysiological Biomarkers for Mood Disorders
Ramakrishnan, N., Murphy, N., Selvaraj, S., & Cho, R. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.015 · Cited by 2
Atualizações científicas sobre a deficiência de vitamina D, de ácido fólico e magnésio na depressão
Baldoino, F. R. R., Mota, G. D. A., Cunha, M. A. A., Melo, H. P., Garcês, T. C. D. C. S., & de Andrade, A. R. O. (2021) · Research Society and Development · doi:10.33448/rsd-v10i2.12572 · Cited by 2
Neuroimaging Studies of Bipolar Depression: Therapeutic Implications
Savitz, J. B., Morris, H. M., & Drevets, W. C. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_8 · Cited by 2
Self-citationRang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00046-9 · Cited by 8
Jain, R., Jackson, W. C., Gardner, N. C., & Maletic, V. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0818 · Cited by 2
“61 Patients with unipolar 62 and bipolar 63 depression tend to have increased activity in the VMPFC. Blumberg et al. 63 found both functional and structural changes in the VMPFC of adolescent and young adult patients with bipolar disorder.”
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50044-x · Cited by 6
Biological Theories of Bipolar Disorder
Blackwood, D., & Muir, W. J. (2004) · Wiley eBooks · doi:10.1002/9780470696385.ch11 · Cited by 2
A Study of Candidate Genes in Depression and Disturbed Sleep
Utge, S. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 2
Neurotrophins and neuronal plasticity in the action of antidepressants and morphine
Sairanen, M. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 2
Resende, R. R., Ulrich, H., & Faria, M. (2007) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488907779561736 · Cited by 2
“Researches on neuroendocrine, neurochemical, neurophysiological, and neuromorphometric abnormalities are being carried out very much independently [ 15-18 ].”
BackgroundBrain TrkB neurotrophin receptor as a target for antidepressant treatments
Rantamäki, T. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 5
Functional and Work Disability and Treatment Received by Patients with Major Depressive Disorder
Rytsälä, H. J. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 2
Biological Models of Unipolar Depression
Cleare, A. J., & Rane, L. J. (2013) · Wiley eBooks · doi:10.1002/9781118316153.ch2 · Cited by 4
Brain damage from recurrent relapses of bipolar mania: A call for early LAI use
Nasrallah, H. A. (2023) · Current Psychiatry · doi:10.12788/cp.0385 · Cited by 1
Sharma, A., Singh, R. P., Sharma, S., Dutt, R., Rana, N., Alshammari, S. O., Alshammari, Q. A., Alshammari, A., Arora, S., Iqbal, M. A., et al. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638363093250324035540 · Cited by 1
Palma-Anzures, I., & Verdugo‐Díaz, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150016 · Cited by 1
Chapter 4.7 The pharmacology of anxiolysis
Holmes, A. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00016-1 · Cited by 1
Gowri, S., & Anand, A. A. P. (2012) · InTech eBooks · doi:10.5772/33287 · Cited by 1
“Alteration of 5-HT (hydroxyl-tryptophan) systems leads to several mental and behavioural problems that include aggression, violence, sexual dysfunction, sleep and eating disorder in humans (Manji et al., 2001) and in rat models, reduction of 5-HT increases aggression (Nelson and Chiavegatto, 2001).”
BackgroundPharmacogenetics of Major Depressive Disorder
Lohoff, F. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080601-05 · Cited by 4
Neuroscience, Molecular Medicine, and New Approaches to the Treatment of Depression and Anxiety
Heninger, G. R. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50013-8 · Cited by 1
Neurobiologic Aspects of Late-Life Mood Disorders
Maletic, V. (2008) · Medical psychiatry · doi:10.3109/9781420053302.008 · Cited by 1
Commentary: Counseling via Analogy
Dunlop, B. W., & Dunlop, A. L. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0606 · Cited by 1
“Substantial data demonstrate alterations in brain function and biochemistry among those with MDD, with normalization of parameters following treatment of MDD via psychotherapy or medication.(32,33) Despite this objective evidence, mental illnesses such as MDD are often viewed by sufferers (and their relatives) as defi…”
MethodPREDICTIVE VALIDITY OF BEHAVIORAL DESPAIR MODELS IN APPRAISING ANTIIMMOBILITY EFFECTS OF ONDANSETRON
Kumar, A. A., Sravani, P., & Priya, V., V (2014) · Cited by 1
The Impact of Long-term Chewing Stimulation Alterations on Anxiety and Cognition in Young Mice*
Su, J., Han, W., Li, Y., Li-Li, C. H. E. N., Gu, J., Ting-Ting, J. I., & Meng, B. (2011) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00620 · Cited by 1
Chen, G., & Manji, H. K. (2007) · Medical psychiatry · doi:10.3109/9781420021158.006 · Cited by 1
Self-citationEffect of venlafaxine on hippocampal BDNF levels in depression-induced rats
Demirdaş, A., Eren, İ., Demirin, H., Aktürk, O., & Vural, H. (2018) · Journal of Cellular Neuroscience and Oxidative Stress · doi:10.37212/jcnos.426634 · Cited by 1
Ke, X., Ma, S., Zhang, Y., Yao, Y., Yu, H., Yu, D., & Pei, L. (2018) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2018.00018 · Cited by 1
Transcranial Direct Current Stimulation-Psychiatric Application and Its Current Status
Pyungkyu, K., & Kim, D. (2017) · Saengmul jeongsin euihag/Saengmul jeongsin uihak · doi:10.22857/kjbp.2017.24.4.002 · Cited by 1
Neurophysiologic Advance in Depressive Disorder
Xu, L., & Mao, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_5 · Cited by 1
Comorbid Psychiatric Illnesses
Thorsteinsson, E., & Brown, R. F. (2019) · Springer eBooks · doi:10.1007/978-3-030-32545-9_6 · Cited by 2
Cleare, A. J., Fekadu, A., & Rane, L. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3397-1.00020-3 · Cited by 2
Brain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1
Involvement of Glial Cells in the Pathophysiology and Treatment of Depression
Fatimi, H. E., & Khalki, L. (2023) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-9675-6.ch017 · Cited by 1
Molecular Mechanisms Regulating Behavior
Ressler, K. J., & Nemeroff, C. B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_123 · Cited by 1
Fator neurotrófico derivado do cérebro (BDNF) no transtorno bipolar : uma metanálise
Fernandes, B. S. (2009) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 1
Idiopathic Depressive Disorders: Basic Principles
Barry, J. J. (2012) · Wiley eBooks · doi:10.1002/9781118348093.ch3 · Cited by 1
Neurotrophic Factors as Novel Therapeutic Targets
Skaper, S. D. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse458 · Cited by 1
Molecular Mechanisms of Action of Mood Stabilizers in Bipolar Disorder
van Calker, D. (2002) · KARGER eBooks · doi:10.1159/000066880 · Cited by 1
“Therefore, in agreement with the effects of mood stabilizers on second messenger systems, they also affects the expression of a number of genes, most likely at least in part also secondary to modulation of PKC and/or GSK3 activity (for review see Manji et al 1995, 2001).”
BackgroundInfluentialStress System Dysregulation in Depression: From Molecular Biology to New Treatment Opportunities
Gold, P. W. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch21 · Cited by 2
In search of animal models for male sexual dysfunction
Chan, J. S. W. (2008) · Utrecht University Repository (Utrecht University) · Cited by 1
Depression, Anxiety, Psychiatric Comorbidity and Dimensions of Temperament and Personality
Jylhä, P. J. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 5
Zaboli, G. (2006) · Figshare · Cited by 1
Lehto, K. (2015) · DSpace repository (University of Tartu) · Cited by 19
Brain galanin sytems and their role in depression-like behaviour
Kuteeva, E. (2007) · Figshare · Cited by 2
Lazowski, L. (2009) · QSpace (Queen's University Library) · Cited by 1
ESCALA CLÍNICA PARA PREVER A ADESÃO AO TRATAMENTO: TRANSTORNO BIPOLAR DO HUMOR
Marchi, R. J. D. (2008) · Americanae (AECID Library) · Cited by 2
Resting-State Functional Connections of the Amygdala in Patients with Major Depressive Disorder
Konduru, N. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27653 · Cited by 2
Effect of high-fat diet-induced obesity on maternal mouse behaviour prepartum and postpartum
Moazzam, S. (2021) · Mspace (University of Manitoba) · Cited by 1
Dunlop, B. W., & Nemeroff, C. B. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb002055 · Cited by 1
Bases biochimiques et neurobiologiques de la psychiatrie
de Beaurepaire, R. (2005) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(05)16945-4 · Cited by 3
Neurobiology of psychiatric disorders
Maletic, V., & DeMuri-Maletic, B. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198746638.003.0005 · Cited by 1
Cichon, J., Joseph, T. T., Wasilczuk, A. Z., Markman, D., Kelz, M. B., & Nägele, P. (2024) · Research Square · doi:10.21203/rs.3.rs-3706278/v1 · Cited by 1
Mendez‐David, I. (2013) · theses.fr (ABES) · doi:10.70675/3b74ce4cz68acz4446zbe46zb1542d4e9391 · Cited by 1
Le récepteur 3 de la neurotensine/Sortiline dans la régulation de l’état dépressif
Moréno, S. (2017) · theses.fr (ABES) · doi:10.70675/bd5432bcz3426z4e54z9081zd99b2eb3f712 · Cited by 1
N-Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression
Skolnick, P., Popik, P., & Trullás, R. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0346-0241-9_1 · Cited by 2
“The marked contrast between the time to achieve steady-state plasma levels (in general, from days to � 1 week for most biogenic amine-based ADs) and the onset of a clinically meaningful effect (in general, � 2‐4 or more weeks in most double blind, placebo controlled trials) [41, 42 ] suggests that neuroplastic change(…”
BackgroundThe genomics of mood disorders
Alesci, S., Rodak, M., Ilias, Ι., Zhou, R., & Manji, H. K. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58006-9 · Cited by 1
Self-citationPotential Utility of Kappa Ligands in the Treatment of Mood Disorders
Carlezon, W. A., & Cohen, B. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_22 · Cited by 1
Razionale farmacologico per l’utilizzazione della quetiapina nel disturbo bipolare
Spina, E. (2006) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology
Metadata
- Authors
- Manji, H. K., Drevets, W. C., & Charney, D. S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 541-547
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1509868652
- Cited by
- 1,182
- References
- 66
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 20 · 2023: 21 · 2022: 33 · 2021: 55 · 2020: 29 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 51 · 2014: 50 · 2013: 60 · 2012: 60
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, neurobiology of depression, neuroplasticity, cell survival, signaling pathways
- MeSH terms
- Antidepressive Agents, Cell Survival, Depressive Disorder, Glucocorticoids, Neuronal Plasticity, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.